Famotidine Powder, For Suspension
Product Images NDC 72603-564

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 72603-564). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig (Famotidine Fig1)

Drug facts and directions panel for Famotidine oral suspension powder USP 40 mg/5 mL by NorthStar Rx LLC. Provides reconstitution instructions, inactive ingredient list, storage conditions, and packaging information for a 50 mL suspension after reconstitution. Includes manufacturer details and cautionary statements about keeping the container tightly closed and out of reach of children.*

FDA Label Image

Str (Famotidine Str)

Chemical structure diagram of famotidine, showing its molecular configuration with atoms and bonds represented in standard line notation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.